Abiopharma

Clinical trial NCT06107738 updates: 1. completion date: 2026-12-31 → 2028-12-31 2. primary completion date: 2025-12-31 → 2027-12-31

Clinical trial NCT07158905 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-08-03 → 2026-06-23

Clinical trial NCT07262567 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2025-12-01 → 2025-12-04

Clinical trial NCT07471841 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-01 → 2026-07-01

Clinical trial NCT07527910 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-04-20 → 2026-05-22 3. completion date: 2029-11-27 → 2030-03-15 4. primary completion date: 2029-11-27 → 2030-03-15

Clinical trial NCT05082285: enrollment: 724 → 726 participants.

Clinical trial NCT06236139: collaborators added: National Cancer Institute (NCI).

Clinical trial NCT06444113: primary completion date: 2026-05-18 → 2026-02-20.

Clinical trial NCT06063057 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05557838 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. start date: 2023-02-22 → 2023-02-15 3. completion date: 2025-03-31 → 2026-09-30 4. primary completion date: 2025-03-31 → 2026-09-30 5. enrollment: 210 → 214 participants 6. enrollment type: ESTIMATED → ACTUAL